Sunshine Biopharma Inc (SBFM)
0.84
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.94
+0.10
(+11.90%)
Pre-Market: 08:02
Sunshine Biopharma Profit Margin (Quarterly): -16.28% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -16.28% |
September 30, 2023 | -10.94% |
June 30, 2023 | -16.22% |
March 31, 2023 | -34.79% |
December 31, 2022 | -596.8% |
September 30, 2022 | -1.10K% |
June 30, 2022 | -358.5% |
March 31, 2022 | -1.01K% |
December 31, 2021 | |
September 30, 2021 | -8.02K% |
June 30, 2021 | -5.45K% |
March 31, 2021 | -15.44K% |
December 31, 2020 | -3.87K% |
September 30, 2020 | -4.07K% |
June 30, 2020 | -5.99K% |
March 31, 2020 | -849.0% |
December 31, 2019 | -3.76K% |
September 30, 2019 | -4.78K% |
Date | Value |
---|---|
June 30, 2019 | -23.44K% |
March 31, 2019 | -98.32K% |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | -291.4% |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | -30.30K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-23.44K%
Minimum
Jun 2019
-10.94%
Maximum
Sep 2023
-4.38K%
Average
-2.43K%
Median
Profit Margin (Quarterly) Benchmarks
Lexaria Bioscience Corp | -448.0% |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | -59.60% |
Edesa Biotech Inc | -- |
Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -20.99% |
Return on Assets | -16.13% |
Return on Invested Capital | -20.99% |
Gross Profit Margin (Quarterly) | 33.44% |
Operating Margin (Quarterly) | -15.46% |
Return on Net Operating Assets | -27.55% |